tiprankstipranks

Matthew Scott Harris Insider Profile

4 Followers
Matthew Scott Harris, CMO at Altimmune, holds 53.63K shares in Altimmune (Ticker: ALT).
tipranks
Matthew Scott Harris

Matthew Scott Harris
Altimmune (ALT)
CMO

Not Ranked
Matthew Scott Harris has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$379K
100.00%
A breakdown of Matthew Scott Harris's holdings

Insider Roles

Altimmune
(ALT)
CMO
Roles that Matthew Scott Harris holds in companies

Most Profitable Insider Trade

Stock:
Altimmune
(ALT)
Rating:Informative Buy
Date:Mar 23, 2023 - Mar 23, 2024
Return:+116.70%
The most profitable trade made by Matthew Scott Harris

Matthew Scott Harris's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Altimmune
Feb 05, 2024
CMO
Uninformative Buy
39.53K
$379.19K
Success Rate for
ALT
1 out of 1 profitable transactions on
ALT
100%
Average Return for
ALT
Average return per transaction on
ALT
+116.70%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 03, 2021
Uninformative Buy
$11.75K
-
$12.14
Aug 06, 2021
Uninformative Buy
$5.58K
-
$7.70
Feb 06, 2023
Uninformative Buy
$35.55K
-
$0.00
Aug 02, 2023
Uninformative Buy
$1.94K
-
$2.81
Feb 01, 2024
Uninformative Buy
$8.76K
-
$2.69
List of latest transactions for each holding click on a transaction to see Matthew Scott Harris's performance on stock

Matthew Scott Harris insider profile FAQ

What is the percentage of profitable transactions made by Matthew Scott Harris?
The percentage of profitable transactions made by Matthew Scott Harris is ―.
    What is the average return per transaction made by Matthew Scott Harris?
    The average return per transaction made by Matthew Scott Harris is ―.
      What stocks does Matthew Scott Harris hold?
      Matthew Scott Harris holds: ALT stocks.
        What was Matthew Scott Harris’s latest transaction?
        Matthew Scott Harris latest transaction was an Uninformative Buy of $39.53K.
          What was Matthew Scott Harris's most profitable transaction?
          Matthew Scott Harris’s most profitable transaction was an Informative Buy of ALT stock on March 23, 2023. The return on the trade was 116.70%.
            What is Matthew Scott Harris's role in Altimmune?
            Matthew Scott Harris's role in Altimmune is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.